Solid First-Quarter Financial Results Reflect Lilly's Continued Momentum into 2022
Lilly's revenue growth in Q1 2022 increased 15%, driven by volume growth of 20%. Excluding revenue from COVID-19 antibodies and Alimta, Q1 2022 revenue grew...
Stay updated with breaking news from Davida Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lilly's revenue growth in Q1 2022 increased 15%, driven by volume growth of 20%. Excluding revenue from COVID-19 antibodies and Alimta, Q1 2022 revenue grew...
Eli Lilly and Co. posted profit of $1.9 billion in the first quarter, up 40%, on higher sales of COVID-19 antibodies and other key products for diabetes, cancer and arthritis.
Lilly's revenue growth in Q1 2022 increased 15%, driven by volume growth of 20%. Excluding revenue from COVID-19 antibodies and Alimta, Q1 2022 revenue grew...
A pharmaceutical company is forcing small animals to swim for their lives. They are drugged, dropped into water, and must swim to save themselves from drowning. This test has been discredited by scientists and other pharmaceutical companies have banned it. Call on the CEO of Eli Lilly to immediately ban the "force to swim test.”
Saturna Capital, an investment management firm, published its “Amana Funds” fourth-quarter 2021 investor letter – a copy of which can be downloaded here.